VLAIO (Flanders Innovation and Entrepreneurship) and Innoviris Brussels awarded the grants to support the discovery of a fibrosis treatment and to expand the applicability of their proprietary Confo® technology. With nearly 45% of all deaths in the developed world, chronic inflammatory and fibrogenic disorders represent a major challenge for today’s medicine. Fibrosis is therefore an important research area for therapeutic drug development.
About Confo Therapeutics
Confo Therapeutics is a drug discovery company built around a disruptive technology, which enables it to address ‘undruggable’ GPCRs. The company is building a portfolio of transformative medicines in various disease areas. Confo Therapeutics is located in Brussels and has recently expanded to a second exploitation site on the technology park in Zwijnaarde/Ghent.
Want to become part of this promising biotech company?
We are delighted to highlight our collaboration with Confo Therapeutics. We are currently looking for a scientist in structural biology, and a research associate in early drug discovery.
Senior Scientist – Structural biology
Confo Therapeutics is looking for a highly motivated and skilled (Senior) Scientist – Structural Biology to strengthen their Drug Discovery team.
Research Associate – Early drug discovery
Confo Therapeutics is looking for a highly motivated and skilled Research Associate – Early Drug Discovery to expand their Target Discovery team.
To keep up to date with HR news, job vacancies and other topics related to the life sciences and industry sectors, join us onLinkedIn or visit the rest of our website!
